Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
The supplement, developed by Nutrapharm, marks the first time a finished product containing Setria has received formal health authority approval in Chile a significant milestone for the ingredient and for Chile's rapidly growing dietary supplement market
doi: 10.1038/s41419-025-07497-0
All peptides supplied by Alixa Pharma are intended strictly for laboratory research purposes only and are not for human consumption, medical, or veterinary use
Join now at www.consumerlab.com/join/ As a ConsumerLab.com member, you may print a copy of this report for your personal use
Reported benefits (per available research): Studied for restoring more youthful pulsatile GH and IGF-1 secretion in older adults, based on a small 1997 randomized, placebo-controlled human trial of a closely related GHRH(1-29) analog published in the Journal of Clinical Endocrinology & Metabolism May support gains in lean body mass in men specifically: that same 16-week trial found a statistically significant increase in lean body mass in men but not in women, alongside a significant increase in skin thickness (a marker of dermal collagen) in both sexes Proposed to support broader recovery and body-composition goals tied to growth-hormone-axis activity, though sermorelin-specific modern adult trial data remains thin, and much of the anti-aging and muscle-building framing used in commercial marketing outpaces the current clinical evidence base Known risks and side effects: Injection-site reactions (pain, swelling, or redness) are the most commonly reported adverse event associated with sermorelin therapy in manufacturer drug-labeling data Headache, flushing, dizziness, difficulty swallowing, hyperactivity, drowsiness, and hives have also been reported less commonly per that same labeling data
US$ 20.49
US$ 25.89
US$ 28.91
US$ 28.94
US$ 23.99
US$ 29.48
